Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacy bodies

Pharmacy indemnity insurance firm appoints chief operating officer after director steps down

John Murphy, the director of the Pharmacists’ Defence Association (PDA), which provides professional indemnity insurance to pharmacists, has retired. The move has triggered a restructure in the body including the appointment of Tom Kirkbride as the PDA’s chief operating officer.

The PDA has around 26,000 members — around half of all practising UK pharmacists — and deals with more than 5,000 incidents per year. It also has a trade union, known as the PDA Union.

Murphy was a general manager when the PDA launched in 2003, and became director in 2008, while Kirkbride has worked in membership bodies such as The Law Society, The Royal Institute of Chartered Surveyors and more recently The Nursing and Midwifery Council.

Mark Koziol, chair of the PDA, says Murphy had made an “outstanding” contribution to the success of the PDA and was “always a calm source of wise advice and never afraid to take on large and powerful organisations”.

“It was only upon his arrival at the PDA that he felt he had truly found his real pharmacy vocation,” he adds, “which was to help fellow professionals in need of support.”

Murphy will continue as a senior advisor to the PDA and as general secretary of the PDA Union.

As well as providing support for pharmacists with legal, practice and employment issues, the PDA seeks to influence the professional, practice and employment agenda to support members.

In particular, it has highlighted how pharmacists are being pressurised by some pharmacy owners to conduct unnecessary medicines use reviews and how this compromises professional integrity.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202192

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • John Murphy, former director of the Pharmacists' Defence Association

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.